Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Generic unit is Endo's most solid
Philly.com
Sunday, August 11, 2013 - 11:13am
tags:
Endo, generics
China Biotech In Review: Fundings For China-Affiliated Drug Companies
Seeking Alpha
Sunday, August 11, 2013 - 11:02am
tags:
Shenogen Pharma, Zhongyuan Union Stem Cell Bioengineering, Sinopharm, ScinoPharm, Mitsubishi Tanabe Pharma, HengHeKangJian Pharmaceutica, Komtur Pharmaceuticals, Allium Medical, Zoetis
Bristol-Myers Squibb's Earnings Made Easy
Motley Fool
Sunday, August 11, 2013 - 10:59am
tags:
Bristol-Myers Squibb, earnings
Teva Gains on Biogen’s Pain as Shares Trim Discount
Bloomberg
Sunday, August 11, 2013 - 10:58am
tags:
Teva, Biogen
This Week in Biotech
Motley Fool
Sunday, August 11, 2013 - 10:57am
tags:
Celgene, CompuGen, Bayer, Isis Pharmaceuticals, Onyx, Novo Nordisk, Amgen
Tonix Pharmaceuticals Announces Pricing of Public Offering of Units and NASDAQ Listing
Healthcare Global
Saturday, August 10, 2013 - 1:30pm
tags:
Tonix Pharmaceuticals
China Investigates Sanofi on Bribery Accusations
Wall Street Journal
Saturday, August 10, 2013 - 1:29pm
tags:
Sanofi, legal
Salix Pharmaceuticals Announces Quarterly Earnings, Beats Expectations By $0.06 EPS
Watch List News
Saturday, August 10, 2013 - 1:27pm
tags:
Salix, earnings
Sun posts loss on Pfizer settlement
DNA India, India
Saturday, August 10, 2013 - 1:26pm
tags:
Sun Pharma, earnings
Star Scientific Q2 Revenues Grow, Net Loss Deepens
Motley Fool
Saturday, August 10, 2013 - 12:41pm
tags:
Star Scientific, earnings
Pfizer's Earnings Made Easy
Motley Fool
Saturday, August 10, 2013 - 12:40pm
tags:
Pfizer, earnings
Keryx's First Step Toward Zerenex Approval
Motley Fool
Saturday, August 10, 2013 - 12:40pm
tags:
Keryx, Zerenex, chronic kidney disease
Is Sanofi Stock A Buy At Current Prices?
Wall Street Cheat Street
Saturday, August 10, 2013 - 12:38pm
tags:
Sanofi
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Saturday, August 10, 2013 - 12:37pm
tags:
Regeneron, earnings
This Company's Debt Might Be a Concern
Motley Fool
Saturday, August 10, 2013 - 12:37pm
tags:
GSK
Can AstraZeneca's New Strategy Save Its Stock?
Motley Fool
Saturday, August 10, 2013 - 12:25pm
tags:
AstraZeneca
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, August 10, 2013 - 12:24pm
tags:
Dendreon, Merrimack Pharmaceuticals, Novavax
Putting Biotech Stocks Under the Microscope
Barron's
Saturday, August 10, 2013 - 12:23pm
tags:
Drug developer MannKind posts larger 2Q loss
Yahoo/AP
Saturday, August 10, 2013 - 12:22pm
tags:
MannKind, earnings
Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
Yahoo/PR Newswire
Saturday, August 10, 2013 - 12:21pm
tags:
Inovio, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.